Estrogen and ADHD
I’ve had more than one patient sit across from me and say some version of:
"I've always been a little scattered, but this is different. I can't finish a sentence. I forget why I walked into a room. I used to be able to power through anything, and now I can't hold a single thought long enough to act on it."
Sure, some of these women had an ADHD diagnosis dating back from childhood or their twenties, but most did not. Most either connected the dots on their own as their focus and attention span imploded in their 40s, or connected them with me during our initial consult.
So what’s going on here? Why are so many women in midlife suddenly showing signs and receiving new diagnoses of ADHD?
Estrogen isn't just a reproductive hormone
Estrogen has receptors all over the brain, including in regions that regulate attention, working memory, and impulse control. One of its most important jobs is supporting dopamine, the neurotransmitter responsible for motivation, focus, and reward. Estrogen helps make dopamine, helps release it, and helps keep it available longer in the synapse.
ADHD is, in large part, a dopamine and norepinephrine regulation issue. So when estrogen drops or swings wildly, as it does throughout perimenopause, the brain's dopamine system takes a hit right alongside it. For a woman who already has an ADHD brain, this is not a subtle change. It can feel like the coping strategies that worked for decades simply stop working overnight.
What the research shows
A 2025 population-based cohort study of over 5,000 women found that women with ADHD had significantly higher perimenopausal symptom scores and that these symptoms presented at an earlier age than in women without ADHD, suggesting an earlier onset of perimenopause in ADHD. Researchers describe how estrogen fluctuates wildly during perimenopause, and many women find their ADHD symptoms grow significantly worse as a result.
The scale of this is bigger than most people realize. A survey of 600 women with ADHD found that 97.5% perceived a worsening of ADHD symptoms during menopause, and 70.4% reported worsening during the postpartum period, underscoring how sensitive ADHD symptoms are to hormonal transitions.
There's also emerging preclinical interest in why some women feel this more intensely than others. Animal research has identified sex differences in how histamine regulates striatal dopamine, with the effect in females modulated by estrogen levels. This raises the possibility of an estrogen-histamine-ADHD interaction, but this has not yet been studied directly in perimenopausal women and remains speculative.
And it isn't only untreated ADHD that shifts. Some women on stimulant or non-stimulant ADHD medication notice their usual dose feels less effective, or side effects feel stronger, as estrogen declines. This is consistent with clinical observations and self-report data, though controlled trials in this population are still lacking. It's a conversation worth having with whoever manages that medication, not something to just push through.
Why this gets missed so often
A few reasons this connection flies under the radar:
- Perimenopause symptoms (brain fog, fatigue, mood swings) and ADHD symptoms (inattention, forgetfulness, emotional reactivity) overlap so much that it's easy to blame one and miss the other.
- Many women were never diagnosed with ADHD as girls, since diagnostic criteria were built around how ADHD tends to present in boys. They spent decades masking and compensating, and perimenopause is often the first time those compensations stop working.
- Most primary care and even psychiatric visits are too short to untangle hormones from attention from mood, so women get handed one prescription at a time without anyone stepping back to look at the whole picture.
What actually helps
It’s worth stating: hormone therapy is not a treatment for ADHD. But if your ADHD symptoms are worsening in the context of perimenopause, stabilizing your estrogen can meaningfully lower the volume on everything else you're dealing with.
In my practice, this usually looks like:
- Starting hormone therapy with an individualized approach (typically estradiol with progesterone for endometrial protection in women with a uterus) using labs and symptom tracking to guide dosing
- Reassessing any existing ADHD medication once hormones are stabilized, since the dose that worked at 38 may not be the right dose at 47
- Ruling out the mimics, especially thyroid dysfunction and iron deficiency, both of which can look exactly like worsening ADHD
- Being honest about what hormones can and can't do. If ADHD symptoms persist after your hormones are optimized, that's a signal to layer in FDA-approved interventions for ADHD
TL;DR: You're not losing your mind! And you’re not making it up.
If you've felt like you're watching your own cognition slip and nobody can tell you why, I want you to hear this: there is a real, physiological explanation, and you deserve a provider who will actually investigate it instead of handing you a pamphlet about "brain fog" and sending you home.
You don't have to just accept this as your new normal.
Let's figure out what's actually going on.
Relevant Research:
Cersosimo MG, Benarroch EE. Estrogen Actions in the Nervous System: Complexity and Clinical Implications. Neurology. 2015.
Golden CEM, Martin AC, Kaur D, et al. Estrogen Modulates Reward Prediction Errors and Reinforcement Learning. Nature Neuroscience. 2025.
Bendis PC, Zimmerman S, Onisiforou A, Zanos P, Georgiou P. The Impact of Estradiol on Serotonin, Glutamate, and Dopamine Systems. Frontiers in Neuroscience. 2023.
Jakobsdóttir Smári U, Valdimarsdottir UA, Wynchank D, et al. Perimenopausal Symptoms in Women With and Without ADHD: A Population-Based Cohort Study. European Psychiatry. 2025.
Osianlis E, Thomas EHX, Li Q, et al. ADHD in Females: Survey Findings on Symptoms Across Hormonal Life Stages. Journal of Psychiatric Research. 2025.
Blasco-Fontecilla H. Is Histamine and Not Acetylcholine the Missing Link Between ADHD and Allergies? Speer Allergic Tension Fatigue Syndrome Re-Visited. Journal of Clinical Medicine. 2023.
Van Zandt M, Pittenger C. Sex Differences in Histamine Regulation of Striatal Dopamine. The Journal of Neuroscience. 2025.
Wynchank D, de Jong M, Kooij SJJS. Practical Tools for Female-Specific ADHD: The Impact of Hormonal Fluctuations in Clinical Practice and From the Literature. European Psychiatry. 2025.
Wynchank D, Kooij S. Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause. Drugs & Aging. 2026.
Wynchank D, Sutrisno RMGTMF, van Andel E, Kooij JJS. Menstrual Cycle-Related Hormonal Fluctuations in ADHD: Effect on Cognitive Functioning-a Narrative Review. Journal of Clinical Medicine. 2025.
